Reuters logo
BRIEF-Paratek Pharmaceuticals Q3 loss per share $0.77
November 8, 2017 / 2:33 PM / 9 days ago

BRIEF-Paratek Pharmaceuticals Q3 loss per share $0.77

Nov 8 (Reuters) - Paratek Pharmaceuticals Inc:

* Paratek Pharmaceuticals reports third quarter 2017 financial results, remains on track to complete NDA submissions in first quarter of 2018

* Q3 loss per share $0.77

* Q3 earnings per share view $-0.94 -- Thomson Reuters I/B/E/S

* Paratek Pharmaceuticals - ‍cash, cash equivalents and marketable securities sufficient to fund operating expenses, Capex requirements through Q2 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below